COVID-19 pandemic and vaccination rate in patients with psoriasis treated with biologics: A single center experience
Background/Aim. Psoriasis is a chronic, immune-mediated, genetically determined disease, which is manifested by the appearance of erythematous scaly plaques. Treatment includes conventional therapies and biologics. The coronavirus disease 2019 (COVID-19) raised widespread concern for patients with p...
Saved in:
| Main Authors: | Milčić Danijela, Malinić Marija, Ćirković Anđa, Krupniković Doroteja, Milinković-Srećković Mirjana |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2024-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | https://doiserbia.nb.rs/img/doi/0042-8450/2024/0042-84502400083M.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy
by: Mateu-Arrom L, et al.
Published: (2025-04-01) -
Hard-to-Treat Areas in Psoriasis: An Underevaluated Part of the Disease
by: Adina-Mihaela Lupulescu, et al.
Published: (2025-03-01) -
Sex-disparities in pediatric and young adult patients with psoriasis treated with biologics: differences in adverse events and disease activity
by: Malak Al-Gawahiri, et al.
Published: (2025-12-01) -
The Hydrogeological and Biological Characteristics of Psoriasis Treatment Center, Turkey
by: Mustafa Değirmenci, et al.
Published: (2021-04-01) -
Role of methotrexate in biologics use with psoriasis and psoriatic arthritis
by: Ting-Ting Cheng, et al.
Published: (2025-04-01)